You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

340 Results
Les cliniques de génétique fournissent des évaluations génétiques (c.-à-d. conseils et tests génétiques) aux femmes, aux personnes trans et aux...
Drug
Other Name(s): Sarclisa®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2024
Document
Jun 2023
Le mot « poitrine » est parfois utilisé pour désigner les seins. Certaines personnes, y compris les hommes transgenres, les personnes transmasculines...
Document
Dec 2023
Document
Dec 2023
Document
Dec 2023
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    iBRUtinib - For the treatment of patients with chronic lymphocytic leukemia (CLL), in combination with venetoclax, based on criteria
Exceptional Access Program
    venetoclax - For the treatment of patients with chronic lymphocytic leukemia (CLL), in combination with ibrutinib, based on criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iBRUtinib,
venetoclax
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025
Guidelines and Advice
Status: Current
ID: GL 19-7
Mar 2024

Pages